Immunosuppression
Showing 1 - 25 of 2,595
Immune Response to Assess Immunosuppression After Liver
Not yet recruiting
- Improve Allograft and Patient Outcomes in Solid Organ Transplantation by Using PPM to Develop Prospective Monitoring
- (no location specified)
Sep 26, 2023
Torque Teno Virus: A Biomarker of Immunosuppression
Recruiting
- Renal Transplant Rejection
- +3 more
- None Observational study
-
London, United KingdomRoyal London Hospital
Feb 23, 2023
Immune Tolerance, Immunosuppression, Liver Transplant; Complications Trial in Tianjin (Tacrolimus or Cyclosporine A)
Not yet recruiting
- Immune Tolerance
- +2 more
- Tacrolimus or Cyclosporine A
-
Tianjin, Tianjin, ChinaTianjin First Central Hospital
Nov 23, 2023
De Novo Metabolic Syndrome in Liver Transplant Patients After
Completed
- Single Transplant
- 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
-
Rome, ItalyRoberta Angelico
Mar 29, 2023
Evaluation of the Impact of Reduced Immunosuppression
Enrolling by invitation
- Graft Vs Host Disease
-
Dallas, TexasMethodist Dallas Medical Center
Dec 20, 2022
Renal Transplant Rejection, Renal Transplant Infection Trial (Tacrolimus)
Not yet recruiting
- Renal Transplant Rejection
- Renal Transplant Infection
- (no location specified)
Nov 1, 2022
Immunosuppression Reduction in Failed Allograft Guided by cfDNA
Recruiting
- Kidney Transplant; Complications
- +2 more
- Blood Draw
-
Minneapolis, MinnesotaUniversity of Minnesota
Oct 21, 2022
Stroke-induced Immunodepression in Neurorehabilitation
Completed
- Stroke
- +2 more
- Neurorehabilitation
-
Pavia, ItalyHeadache Science & Neurorehabilitation Center
Jun 1, 2023
Kidney Transplant, BK Viremia Trial (Intravenous immunoglobulin)
Not yet recruiting
- BK Viremia
- +2 more
- Immunosuppression reduction/modification + intravenous immunoglobulin
- Immunosuppression reduction/modification
- (no location specified)
Oct 16, 2022
Heart Transplant Rejection, Immune Suppression, Pediatric Heart Transplant Trial in Gainesville (DOT intervention)
Not yet recruiting
- Heart Transplant Rejection
- +3 more
- DOT intervention
-
Gainesville, FloridaUniversity of Florida
Feb 8, 2023
TruGraf Liver Gene Expression Serial Test
Not yet recruiting
- Autoimmune Liver Disease
- +3 more
- TruGraf®
- (no location specified)
Sep 27, 2023
Metastatic Melanoma, Metastatic Breast Cancer, Advanced Renal Cell Carcinoma Trial in Worldwide (single arm)
Withdrawn
- Metastatic Melanoma
- +5 more
- single arm
- (no location specified)
Dec 20, 2022
Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,
Recruiting
- Kidney Transplant Recipients
- Liver Transplant Recipients
- Pfizer-BioNTech Bivalent COVID-19 Vaccine
- +3 more
-
San Diego, California
- +14 more
Oct 31, 2022
COVID-19 Trial in Vienna (Immunosuppression reduction, No immunosuppression reduction)
Active, not recruiting
- COVID-19
- Immunosuppression reduction
- No immunosuppression reduction
-
Vienna, AustriaMedical University of Vienna
Apr 16, 2022
Quantifying Systemic Immunosuppression to Personalize Cancer
Recruiting
- Melanoma
- +6 more
- MDSC quantification
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Nov 11, 2022
Immune Dysregulation in Patients With COVID-19
Recruiting
- COVID-19
- Immunosuppression
- mid covid-19 patients
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jan 6, 2023
Anti-COVID-19 Humoral and Memory T Cell Responses in Various
Active, not recruiting
- Immune Response
- blood collection
-
Paris, FranceHôpital Robert Debré
Sep 15, 2022
Patients Receiving Mismatched Allogeneic HCT Trial in Germany (immunosuppression)
Terminated
- Patients Receiving Mismatched Allogeneic HCT
- immunosuppression
-
Mainz, Germany
- +3 more
Jun 29, 2022
Immunosuppression, COVID-19 Trial in Madison (NVX-CoV2372)
Not yet recruiting
- Immunosuppression
- COVID-19
- NVX-CoV2372
-
Madison, WisconsinUW School of Medicine and Public Health
Aug 31, 2023
Lymphoma Trial in Stanford (rituximab)
Completed
- Lymphoma
- rituximab
-
Stanford, CaliforniaStanford University Medical Center
May 25, 2022
Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)
Recruiting
- Solid Tumor Malignancy
- +4 more
- mRNA-1273
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 14, 2023
Myocarditis, Heart Failure, Endomyocardial Biopsy Trial in Warsaw (Prednisone, Azathioprine, Placebo Prednisone)
Not yet recruiting
- Myocarditis
- +4 more
- Prednisone
- +3 more
-
Warsaw, PolandFirst Department of Cardiology, Medical University of Warsaw
Apr 26, 2022
COVID-19, Immunosuppression, Vaccine Response Impaired Trial in Sacramento (Reduction in antimetabolite immunosuppression)
Recruiting
- COVID-19
- +2 more
- Reduction in antimetabolite immunosuppression
-
Sacramento, CaliforniaUniversity of California, Davis
Feb 7, 2022
Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Intraocular Pressure Trial (Fluorometholone 0.1% Oph Susp,
Not yet recruiting
- Pseudophakic Bullous Keratopathy
- +2 more
- Fluorometholone 0.1% Oph Susp
- +2 more
- (no location specified)
Feb 7, 2023
Infection, Transplant;Failure,Kidney Trial in San Francisco (Mycophenolate Mofetil)
Withdrawn
- Infection
- Transplant;Failure,Kidney
- Mycophenolate Mofetil
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 2, 2022